{"nctId":"NCT01248416","briefTitle":"Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature","startDateStruct":{"date":"2010-11"},"conditions":["Idiopathic Short Stature"],"count":76,"armGroups":[{"label":"Aromatase Inhibitor","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Aromatase Inhibitor"]},{"label":"Growth Hormone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Growth Hormone"]},{"label":"Aromatase Inhibitor and Growth Hormone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Aromatase Inhibitor","Drug: Growth Hormone","Drug: Aromatase Inhibitor and Growth Hormone"]}],"interventions":[{"name":"Aromatase Inhibitor","otherNames":["Arimidex (Anastrozole)","Femara (Letrozole)"]},{"name":"Growth Hormone","otherNames":["Nutropin (Somatropin)","Genotropin (Somatropin)"]},{"name":"Aromatase Inhibitor and Growth Hormone","otherNames":["Arimidex (Anastrozole)","Femara (Letrozole)","Nutropin (Somatropin)","Genotropin (Somatropin)"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Males: Ages: 12 - less than 18 years.\n* Bone age less than 14 Â½ years at study initiation.\n* Presence of puberty.\n* Idiopathic short stature will be defined as a short child equal or less than -2SD for height, with normal GH responses to stimuli (\\> or = 5ng/ml to at least 2 secretagogues) or a normal IGF-I and BP-3, normal body proportions and no other identifiable growth pathology.\n* Accurate growth data for at least 6 months at baseline is available.\n\nExclusion Criteria:\n\n* Chronic illnesses.\n* Chronic use of glucocorticosteroids.\n* Previous use of hormonal treatment with AIs, sex steroids or GH in the preceding 6 months.\n* Birth weight small for gestational age (SGA).","healthyVolunteers":false,"sex":"MALE","minimumAge":"12 Years","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Height","description":"Differences in height gains","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":"0.8"},{"groupId":"OG001","value":"17.1","spread":"0.9"},{"groupId":"OG002","value":"18.9","spread":"0.8"}]}]}]},{"type":"PRIMARY","title":"Change in Predicted Height","description":"Primary efficacy end point: change in predicted height (cm) from baseline at 24 months based on change in bone age (years)","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"1.0"},{"groupId":"OG001","value":"4.9","spread":"0.9"},{"groupId":"OG002","value":"7.4","spread":"0.9"}]}]}]},{"type":"SECONDARY","title":"Change in Bone Density z Score Adjusted for Height","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.061","spread":"0.313"},{"groupId":"OG001","value":"-0.586","spread":"0.244"},{"groupId":"OG002","value":"-0.605","spread":"0.257"}]}]}]},{"type":"SECONDARY","title":"Change in Lean Body Mass","description":null,"paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42.2","spread":"1.6"},{"groupId":"OG001","value":"42.0","spread":"1.3"},{"groupId":"OG002","value":"46.5","spread":"1.2"}]}]}]},{"type":"SECONDARY","title":"Change in Body Mass Index","description":null,"paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":"0.3"},{"groupId":"OG001","value":"1.7","spread":"0.4"},{"groupId":"OG002","value":"2.5","spread":"0.4"}]}]}]},{"type":"SECONDARY","title":"Change in IGF-I Concentrations","description":null,"paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"158","spread":"14"},{"groupId":"OG001","value":"280","spread":"16"},{"groupId":"OG002","value":"303","spread":"27"}]}]}]},{"type":"SECONDARY","title":"Change in Testosterone","description":null,"paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"737","spread":"79"},{"groupId":"OG001","value":"372","spread":"33"},{"groupId":"OG002","value":"668","spread":"37"}]}]}]},{"type":"SECONDARY","title":"Change in Estradiol","description":"Those taking AI alone or AI/GH combined were grouped by type, either anastrozole or letrozole.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":"1"},{"groupId":"OG001","value":"4","spread":"1"}]}]}]},{"type":"SECONDARY","title":"Change in Estrone","description":null,"paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"1.7"},{"groupId":"OG001","value":"6.1","spread":"0.9"},{"groupId":"OG002","value":"-0.9","spread":"1.3"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":25},"commonTop":[]}}}